Survival data in patients with HGBL and non-HGBL. Survival was evaluated from eligibility (A, OS); from CAR T-cell infusion in the whole group (B, PFS; C, OS); and after infusion in the subgroup of patients who received axi-cel (D, PFS; E, OS). NA, non atteint (not reached).